Convert edgeX EDGEX to VitaFOXO VITAFOXO

EdgeX is a decentralized perpetual futures exchange that combines the speed and performance of centralized exchanges with the transparency and self-custody of DeFi. The platform features an off-chain order matching engine with on-chain settlement, enabling high-speed, low-latency trading across a wide range of crypto assets.  Due to a ticker collision, Coinbase will use the ticker "EDGEX" for this asset instead of its on-chain or MiCA whitepaper designation "EDGE". This adjustment ensures compatibility with existing assets on our platform and avoids potential conflicts. The change does not affect the underlying asset's functionality or value.

This project will design a new RNA therapeutic that nudges the longevity-linked FOXO3 gene into its health-promoting form to halt the tissue breakdown behind degenerative disc disease—opening a precise, scalable route to drugs that extend healthspan. Dr. Lorna Harries’ lab has identified an innovative way to modulate FOXO3, a well known and yet undrugged longevity target, and propose leveraging it to address chronic lower back pain stemming from degenerative disc disease. They plan to make short, lab-made modified RNA molecules (antisense oligonucleotides) that selectively switch FOXO3’s “good” message on, first in human cells and mini-disc models. Success would yield 1) a lead drug candidate, 2) proof it can restore disc health, and 3) the data needed for patenting and further development. The same molecules could later be adapted to treat many other age-related conditions, helping people stay healthy for longer.